Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
O WirtaP Laippala

Abstract

The objective was to evaluate the impact of urinary albumin excretion rate (UAER), glomerular filtration rate (GFR) and subclinical autonomic neuropathy (SANP) on 9-year total (TM) and sudden cardiac mortality (SCM) in recently diagnosed (< 1 year; RD; n = 150) and known (mean duration 11 years; KD; n = 146) NIDDM subjects. The study was prospective and controlled (n = 150). Mortality predictors were analysed by logistic regression analysis. The dependent variables were TM and SCM, the predictors were UAER, GFR, SANP, age, gender, BMI, mean arterial pressure (MAP), fasting serum cholesterol, HDL-cholesterol, triglycerides, insulin, haemoglobin A1c, diabetes duration, QTc-interval (ECG), coronary heart disease (CHD), peripheral vascular disease (PVD), cerebrovascular disease (CVD), congestive heart failure (CHF), antihypertensive therapy, and smoking habits. CHD predicted TM and SCM in both RD (P = 0.041 and 0.029) and KD (P = 0.034 and 0.006). PVD predicted TM and SCM in KD only (P = 0.001 and 0.003). CVD predicted TM and SCM in RD only (P = 0.001 and 0.017). In RD male gender (P = 0.049), fasting serum cholesterol (P = 0.007) and CHF (P = 0.001) predicted TM and in kDa haemoglobin A1c (P = 0.004), age (P = 0.001) and MAP (P = ...Continue Reading

Citations

Jun 27, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Matthias Weck
May 11, 2004·Current Diabetes Reports·Fadi A El-AtatJ Thomas Bigger
Sep 4, 1999·Clinical and Experimental Pharmacology & Physiology·S P McDonaldW E Hoy
May 6, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·Y GroeneveldM P Springer
Jan 25, 2002·Postȩpy higieny i medycyny doświadczalnej·A Piwowar, M Warwas
Jul 14, 2010·European Journal of Medical Research·C MeyerT Rassaf
Oct 29, 2010·International Journal of Cardiology·Tienush RassafChristian Meyer
Jul 1, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Zaimin WangKevan R Polkinghorne
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·S H KoY B Ahn
Dec 22, 2010·European Journal of Medical Research·T RassafChristian Meyer
Oct 29, 2002·Diabetes Care·Allon N FriedmanUNKNOWN Collaborative Study Group
Feb 13, 2009·Renal Failure·Helen A TzanatosEirini Grapsa
Aug 10, 2001·Current Opinion in Nephrology and Hypertension·L D Dworkin
May 8, 2004·Journal of Endocrinological Investigation·M VeglioP Cavallo-Perin
May 10, 2005·QJM : Monthly Journal of the Association of Physicians·V BaskarB M Singh
Jun 30, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A G Bostom, L D Dworkin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.